ITGB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.201600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.447000E-01
Normal-vs-Stage2
7.891400E-01
Normal-vs-Stage3
5.272400E-01
Normal-vs-Stage4
7.605800E-01
Stage1-vs-Stage2
5.091200E-01
Stage1-vs-Stage3
7.814400E-01
Stage1-vs-Stage4
1.367800E-01
Stage2-vs-Stage3
4.328200E-01
Stage2-vs-Stage4
4.118600E-01
Stage3-vs-Stage4
1.331790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.689800E-01
Normal-vs-AfricanAmerican
9.343000E-01
Normal-vs-Asian
7.034200E-01
Caucasian-vs-AfricanAmerican
4.351400E-01
Caucasian-vs-Asian
8.826000E-01
AfricanAmerican-vs-Asian
5.137000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.623400E-01
Normal-vs-Female
6.807200E-01
Male-vs-Female
8.494800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.116600E-01
Normal-vs-Age(41-60Yrs)
7.593000E-01
Normal-vs-Age(61-80Yrs)
5.203800E-01
Normal-vs-Age(81-100Yrs)
4.045600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.693790E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.426800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.061600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.570600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.483500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.850400E-01
Normal-vs-Daily Drinker
4.093600E-01
Normal-vs-Weekly Drinker
7.390200E-01
Normal-vs-Occasional Drinker
9.387800E-01
Normal-vs-Social Drinker
7.425400E-01
Non Drinker-vs-Daily Drinker
9.085800E-01
Non Drinker-vs-Weekly Drinker
4.226000E-01
Non Drinker-vs-Occasional Drinker
1.662170E-01
Non Drinker-vs-Social Drinker
4.982200E-01
Daily Drinker-vs-Weekly Drinker
4.236600E-01
Daily Drinker-vs-Occasional Drinker
1.623580E-01
Daily Drinker-vs-Social Drinker
4.958200E-01
Weekly Drinker-vs-Occasional Drinker
5.089000E-01
Weekly Drinker-vs-Social Drinker
9.523800E-01
Occasional Drinker-vs-Social Drinker
4.863400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.647800E-01
Normal-vs-Grade 2
3.539600E-02
Normal-vs-Grade 3
7.506100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.513900E-02
Grade 1-vs-Grade 3
5.000000E-02
Grade 1-vs-Grade 4
2.647800E-01
Grade 2-vs-Grade 3
7.388200E-01
Grade 2-vs-Grade 4
3.539600E-02
Grade 3-vs-Grade 4
7.506100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.882600E-01
Normal-vs-NonDiabetic
6.800400E-01
Diabetic-vs-NonDiabetic
5.234400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.820400E-01
Normal-vs-NoPancreatitis
6.422000E-01
Pancreatitis-vs-NoPancreatitis
5.868400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.121000E-01
Normal-vs-N1
7.742800E-01
N0-vs-N1
3.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.629200E-01
Normal-vs-TP53-NonMutant
2.210200E-01
TP53-Mutant-vs-TP53-NonMutant
2.823300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
